Andres Duarte, MD
Hepatology · Chicago, ILNPI 1043520380
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,775 of the $10,750 with a category attached, or 90.9%. Gilead accounts for 64.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $3,944 and has fallen 84.8% since, to $599 in 2025.
Across 21 payments — averaging $511.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$7K
- Mallinckrodt Hospital Products Inc.$3K
- Novo Nordisk$379
- Madrigal Pharmaceuticals$167
- Cook Medical LLC$128
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$55
- plus $106 from 4 others
What the payments were for
- Consulting fees$9,77591%
- Food & beverage$8758%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 2 | $6,875 |
| Mallinckrodt Hospital Products Inc. | 2 | $3,041 |
| Novo Nordisk | 7 | $379 |
| Madrigal Pharmaceuticals | 2 | $167 |
| Cook Medical LLC | 1 | $128 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $55 |
| AbbVie | 1 | $36 |
| Mallinckrodt Enterprises LLC | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TERLIVAZ$141
- ECHOTIP INSIGHT$128
- REZDIFFRA$110
How this compares
$10,750 in reported general payments places this provider in the 65th percentile of 21 hepatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 15 | $22,599 |
| Tacrolimus | 105 | $18,604 |
| LokelmaSodium Zirconium Cyclosilicate | 32 | $17,348 |
| Atovaquone | 14 | $10,003 |
| Ursodiol | 46 | $5,265 |
| Mycophenolic AcidMycophenolate Sodium | 11 | $2,040 |
| Mycophenolate Mofetil | 52 | $2,003 |
| Carvedilol | 58 | $999 |
| Amlodipine Besylate | 54 | $522 |
| Lactulose | 27 | $436 |
| Atorvastatin Calcium | 33 | $383 |
| Nifedipine ErNifedipine | 11 | $323 |
| Pantoprazole Sodium | 33 | $317 |
| Tamsulosin Hcl | 12 | $280 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $279 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $55 | $22,59915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 21 hepatology providers in Illinois.
Other hepatology in Chicago
- Sean KoppeChicago$152K
- Veronica LoyChicago$78K
- Amanda CheungChicago$64K
- Daniel GangerChicago$58K
- Christopher MooreChicago$57K
- Justin BoikeChicago$24K
- Anna PatelChicago$6K
- Sarang ThakerChicago$6K
- Sheila EswaranChicago$1K
- Sonu DhillonChicago$995
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.